Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy - Cuylan, Z F; Meydanli, M M; Sari, M E (J Obstet Gynaecol Res, 2018)